Gary M. Bertman, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 157 Montauk Ave, New London, CT 06320 Phone: 860-437-0333 Fax: 860-439-1330 |
Dr. Eric Fisher, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Shaws Cv, Suite 103, New London, CT 06320 Phone: 860-443-3778 Fax: 860-443-8820 |
Daniel Rissi, M.D. Family Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-442-0711 Fax: 860-444-3741 |
Steven Paul Johnson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4 Shaws Cv, Ste 103, New London, CT 06320 Phone: 860-443-3778 Fax: 860-443-8820 |
News Archive
A team of researchers at King's College London, UK, and other institutions used publicly accessible sources of real-world data, such as online health forums. They found that authors of COVID-19 related posts most frequently mentioned mental health symptom keywords during the first wave, followed by physical symptoms and intensive care keywords.
A team of doctors and scientists from the Champalimaud Clinical Centre in Lisbon, Portugal, and the Netherlands Cancer Institute in Amsterdam, has shown that patients with "low" rectal cancer (that is, very close to the anus) who show no sign of their tumors after a course of radio- and chemotherapy can safely choose to postpone invasive and complication-prone surgical procedures.
As many Americans continue to grow older, another large part of the population is faced with the growing problem of obesity: both of these conditions can adversely impact mobility and ultimately, patients' independence.
The term 'morning sickness' is misleading and should instead be described as nausea and sickness in pregnancy, argue researchers led by the University of Warwick who have demonstrated that these symptoms can occur at any time of the day - not just the morning.
SIn 2012, The Ben & Catherine Ivy Foundation awarded $10 million in grants for two groundbreaking brain cancer research projects at the Translational Genomics Research Institute. One of those projects has officially received the final regulatory approval from University of California, San Francisco, which means patient enrollment for the trial can begin.
› Verified 1 days ago